Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,150.00
0.00 (0.00%)
Apr 20, 2026, 5:29 PM IDT
TLV:REKA Revenue
In the year 2025, Rekah Pharmaceutical Industry had annual revenue of 300.99M ILS, down -6.44%. Rekah Pharmaceutical Industry had revenue of 76.91M in the quarter ending December 31, 2025, with 0.98% growth.
Revenue
300.99M
Revenue Growth
-6.44%
P/S Ratio
0.44
Revenue / Employee
714.94K
Employees
421
Market Cap
131.27M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 300.99M | -20.72M | -6.44% |
| Dec 31, 2024 | 321.71M | 49.00K | 0.02% |
| Dec 31, 2023 | 321.66M | 29.27M | 10.01% |
| Dec 31, 2022 | 292.39M | 28.44M | 10.78% |
| Dec 31, 2021 | 263.95M | -1.52M | -0.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.02B |
| Danel (Adir Yeoshua) | 2.90B |
| Amal Holdings A.D. | 2.18B |
| Nissan Medical Industries | 651.78M |
| InterCure | 243.12M |
| BrainsWay | 166.49M |
| Seach Medical Group | 157.15M |
| Golden House | 46.05M |